The SAFE Sunscreen Standards Act aims to speed up the approval process for new sunscreen ingredients by modernizing how the Food and Drug Administration (FDA) evaluates their safety and effectiveness. The bill requires the FDA to establish clear standards that allow for real-world evidence and non-animal testing methods in addition to traditional clinical trials, and mandates that the agency issue guidance within 180 days on how companies can use alternative testing approaches. This legislation directly affects sunscreen manufacturers and consumers seeking access to new sun protection products, as no new sunscreen active ingredients have been approved in the United States since 1999 despite growing skin cancer rates, which now exceed 9,500 diagnoses per day. The bill also requires the FDA to submit annual reports to Congress starting one year after enactment detailing the implementation of these new standards and progress on approving pending sunscreen ingredient applications. By removing regulatory barriers while maintaining safety requirements, the bill intends to bring innovative sunscreen products to market faster and improve Americans' ability to prevent skin cancer.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.